<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000644318"><TermName>laromustine</TermName><TermPronunciation>(LAYR-oh-MUS-teen)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat acute myelogenous leukemia (AML). It is also being studied in the treatment of several other types of cancer. It blocks cell growth by damaging the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Cloretazine and Onrigin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726067" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;laromustine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726066" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;laromustina&quot;" language="es" id="_4"/><SpanishTermName>laromustina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la leucemia mielógena aguda (LMA). También está en estudio para el tratamiento de otros tipos de cáncer. Impide el crecimiento de las células dañándoles  el ADN y podría destruir las células cancerosas. Es un tipo de alquilante. También se llama Cloretazine y Onrigin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-10-05</DateFirstPublished></GlossaryTerm>
